Recursion Pharmaceuticals, Inc. Class A Common Stock RXRX
$4.05
+2.02%
at last close
Financials (TTM)
- Revenue
- $54.85 million
- Net Income
- $-518,884,000
- Net Margin
- -945.92%
- Return on Equity
- -56.71%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.37
- Price / Sales
- 39.59
Over the trailing twelve months, Recursion Pharmaceuticals, Inc. Class A Common Stock generated revenue of $54.85 million and net income of $-518,884,000, a net margin of -945.92%.
At the last closing price of $4.05, RXRX trades at 39.59 times sales, with a market capitalization of $2.17 billion.
Key Stats
- Last Close
- $4.05
- Market Cap
- $2.17 billion
- 52-Week Range
- $2.77 – $7.18
- Average Volume
- 17.98 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.